Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 68,394
Sort by:

Deep Vein Thrombosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major deep vein thrombosis markets reached a value of US$ 458.6 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 905.9 Million by 2034, exhibiting a growth rate (CAGR)...

May 2024 128 pages

Deglutition Disorders Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major deglutition disorders markets are expected to exhibit a CAGR of 4.1% during 2024-2034. The deglutition disorders market has been comprehensively analyzed in IMARC's new report titled 'Degl...

May 2024 138 pages

Delirium Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major delirium markets reached a value of US$ 187.2 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 283.0 Million by 2034, exhibiting a growth rate (CAGR) of 3.83% dur...

May 2024 140 pages

Dementia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dementia markets reached a value of US$ 6.8 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 12.8 Billion by 2034, exhibiting a growth rate (CAGR) of 5.85% during...

May 2024 128 pages

Dengue Fever Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dengue fever markets are expected to exhibit a CAGR of 10.21% during 2024-2034. The dengue fever market has been comprehensively analyzed in IMARC's new report titled 'Dengue Fever Market:...

May 2024 135 pages

Dermatomycosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dermatomycosis markets are expected to exhibit a CAGR of 3.47% during 2024-2034. The dermatomycosis market has been comprehensively analyzed in IMARC's new report titled 'Dermatomycosis Ma...

May 2024 128 pages

Dermatomyositis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dermatomyositis markets reached a value of US$ 192.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 278.0 Million by 2034, exhibiting a growth rate (CAGR) of 3....

May 2024 128 pages

Desmoid Tumors Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major desmoid tumors markets reached a value of US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.2 Billion by 2034, exhibiting a growth rate (CAGR) of 5.61% d...

May 2024 140 pages

Diabetic Foot Ulcers Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major diabetic foot ulcers markets reached a value of US$ 3.5 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 5.4 Billion by 2034, exhibiting a growth rate (CAGR) of 3...

May 2024 134 pages

Diabetic Ketoacidosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major diabetic ketoacidosis markets are expected to exhibit a CAGR of 4.38% during 2024-2034. The diabetic ketoacidosis market has been comprehensively analyzed in IMARC's new report titled 'Dia...

May 2024 133 pages

Diabetic Macular Edema Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major diabetic macular edema market reached a value of US$ 5.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 7.5 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 138 pages

Diabetic Nephropathy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major diabetic nephropathy markets reached a value of US$ 9,717.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 14,572.9 Million by 2034, exhibiting a growth rate (C...

May 2024 134 pages

Diabetic Neuropathy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2034

US$ 6,499.00

The 7 major diabetic neuropathy markets reached a value of US$ 2.9 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4.9 Billion by 2034, exhibiting a growth rate (CAGR) of 5....

May 2024 131 pages

Diabetic Peripheral Neuropathy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major diabetic peripheral neuropathy markets reached a value of US$ 2,903.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 5,365.9 Million by 2034, exhibiting a growt...

May 2024 134 pages

Diffuse Intrinsic Pontine Glioma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major diffuse intrinsic pontine glioma markets reached a value of US$ 3.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 5.4 Billion by 2034, exhibiting a growth rate...

May 2024 130 pages

DiGeorge Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major diGeorge syndrome markets are expected to exhibit a CAGR of 4.78% during 2024-2034. The DiGeorge Syndrome market has been comprehensively analyzed in IMARC's new report titled 'DiGeorge Sy...

May 2024 134 pages

Diphtheria Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major diphtheria markets are expected to exhibit a CAGR of 4.31% during 2024-2034. The diphtheria market has been comprehensively analyzed in IMARC's new report titled 'Diphtheria Market: Epidem...

May 2024 138 pages

Donohue Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Donohue syndrome markets reached a value of US$ 11.9 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 22.6 Billion by 2034, exhibiting a growth rate (CAGR) of 6.0...

May 2024 129 pages

Doose Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major doose syndrome markets reached a value of US$ 687.2 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3,160.7 Million by 2034, exhibiting a growth rate (CAGR) of 1...

May 2024 136 pages

Down Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast ?2024-2034?

US$ 6,499.00

The 7 major down syndrome markets reached a value of US$ 1.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.8 Billion by 2034, exhibiting a growth rate (CAGR) of 10.91% d...

May 2024 137 pages

Dravet Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Dravet syndrome markets reached a value of US$ 375.8 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 796.3 Million by 2034, exhibiting a growth rate (CAGR) of 7....

May 2024 135 pages

Drug-Resistant Epilepsy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major drug-resistant epilepsy markets reached a value of US$ 3.6 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 6.0 Billion by 2034, exhibiting a growth rate (CAGR) o...

May 2024 137 pages

Dry Age Macular Degeneration Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dry age macular degeneration markets are expected to exhibit a CAGR of 4.64% during 2024-2034. The dry age macular degeneration market has been comprehensively analyzed in IMARC's new repo...

May 2024 136 pages

Dupuytren's Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Dupuytren's disease markets are expected to exhibit a CAGR of 3.76% during 2024-2034. The Dupuytren's disease market has been comprehensively analyzed in IMARC's new report titled 'Dupuytr...

May 2024 136 pages

Dysautonomia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dysautonomia markets reached a value of US$ 2.1 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 5.5 Billion by 2034, exhibiting a growth rate (CAGR) of 9.22% dur...

May 2024 131 pages

Dyskinesia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dyskinesia markets are expected to exhibit a CAGR of 3.14% during 2024-2034. The dyskinesia market has been comprehensively analyzed in IMARC's new report titled 'Dyskinesia Market: Epidem...

May 2024 130 pages

Dyslipidemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dyslipidemia markets reached a value of US$ 5.8 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 8.8 Billion by 2034, exhibiting a growth rate (CAGR) of 3.84% dur...

May 2024 133 pages

Dysmenorrhea Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dysmenorrhea markets reached a value of US$ 10.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 18.5 Billion by 2034, exhibiting a growth rate (CAGR) of 5.44% d...

May 2024 128 pages

Dyspepsia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dyspepsia markets are expected to exhibit a CAGR of 3.49% during 2024-2034. The dyspepsia market has been comprehensively analyzed in IMARC's new report titled 'Dyspepsia Market: Epidemiol...

May 2024 128 pages

Dyspnea Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dyspnea markets are expected to exhibit a CAGR of 5.24% during 2024-2034. The dyspnea market has been comprehensively analyzed in IMARC's new report titled 'Dyspnea Market: Epidemiology, I...

May 2024 132 pages

Dyssomnias Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dyssomnias markets reached a value of US$ 16.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 19.3 Billion by 2034, exhibiting a growth rate (CAGR) of 1.68% dur...

May 2024 139 pages

Dysthymia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dysthymia markets are expected to exhibit a CAGR of 3.7% during 2024-2034. The dysthymia market has been comprehensively analyzed in IMARC's new report titled 'Dysthymia Market: Epidemiolo...

May 2024 130 pages

Dystrophic Epidermolysis Bullosa Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2034

US$ 6,499.00

The 7 major dystrophic epidermolysis bullosa markets reached a value of US$ 525.8 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,857.8 Million by 2034, exhibiting a growt...

May 2024 132 pages

Eczema Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major eczema markets reached a value of US$ 16.8 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 37.1 Billion by 2034, exhibiting a growth rate (CAGR) of 7.46% during...

May 2024 136 pages

Edward’s Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Edward’s syndrome markets reached a value of US$ 3.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 7.6 Billion by 2034, exhibiting a growth rate (CAGR) of 7.51...

May 2024 128 pages

EGFR Inhibitors-Induced Skin Disorders Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major EGFR inhibitors-induced skin disorders markets are expected to exhibit a CAGR of 17.89% during 2024-2034. The EGFR inhibitors-induced skin disorders market has been comprehensively analyze...

May 2024 135 pages

Ehlers-Danlos Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Ehlers-Danlos syndrome markets are expected to exhibit a CAGR of 3.42% during 2024-2034. The Ehlers-Danlos syndrome market has been comprehensively analyzed in IMARC's new report titled 'E...

May 2024 138 pages

Emesis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major emesis markets are expected to exhibit a CAGR of 4.18% during 2024-2034. The emesis market has been comprehensively analyzed in IMARC's new report titled 'Emesis Market: Epidemiology, Indu...

May 2024 140 pages

Emphysema Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major emphysema markets reached a value of US$ 3.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4.9 Billion by 2034, exhibiting a growth rate (CAGR) of 3.84% during...

May 2024 137 pages

Encephalitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major encephalitis markets reached a value of US$ 15.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 23.4 Billion by 2034, exhibiting a growth rate (CAGR) of 4.1% du...

May 2024 137 pages

End-Stage Renal Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major end-stage renal disease markets reached a value of US$ 76.6 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 218.2 Billion by 2034, exhibiting a growth rate (CAGR...

May 2024 137 pages

Endocarditis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major endocarditis markets are expected to exhibit a CAGR of 4.22% during 2024-2034. The endocarditis market has been comprehensively analyzed in IMARC's new report titled 'Endocarditis Market:...

May 2024 131 pages

Endometrial Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major endometrial cancer markets reached a value of US$ 20.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 29.5 Billion by 2034, exhibiting a growth rate (CAGR) of 3...

May 2024 133 pages

Eosinophilia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major eosinophilia markets reached a value of US$ 289.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 474.5 Million by 2034, exhibiting a growth rate (CAGR) of 4.61%...

May 2024 131 pages

Eosinophilic Esophagitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major eosinophilic esophagitis markets reached a value of US$ 896.3 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 7,604.7 Million by 2034, exhibiting a growth rate (...

May 2024 137 pages

Ependymoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major ependymoma markets are expected to exhibit a CAGR of 4.03% during 2024-2034. The ependymoma market has been comprehensively analyzed in IMARC's new report titled 'Ependymoma Market: Epidem...

May 2024 131 pages

Epidermolysis Bullosa Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major epidermolysis bullosa markets reached a value of US$ 2,596.3 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3,929.8 Million by 2034, exhibiting a growth rate (C...

May 2024 131 pages

Epithelial Ovarian Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major epithelial ovarian cancer markets reached a value of US$ 2.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 14.3 Billion by 2034, exhibiting a growth rate (CAGR...

May 2024 134 pages

Erdheim-Chester Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Erdheim-Chester disease markets are expected to exhibit a CAGR of 7.13% during 2024-2034. The Erdheim-Chester disease market has been comprehensively analyzed in IMARC's new report titled...

May 2024 135 pages

Erectile Dysfunction Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major erectile dysfunction markets reached a value of US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.9 Billion by 2034, exhibiting a growth rate (CAGR) of 6...

May 2024 133 pages

Filters

Search

Categories

185
933
31
215
180
152
135
116
63,606
1,032
750
910
149

Publishers

179
1
239
347
389
103
826
148
348
3
202
3
6
1,620
487
76
123
208
111
25
1,049
378
23
40
68
472
277
34
29,954
248
501
3,036
1
1
2
3
16
536
361
1
1,357
1,790
60
1,696
8
7,373
2,208
4,555
321
66
3
36
200
29
29
143
42
83
3
281
85
20
6
43
14
1
178
48
359
36
44
10
11
18
168
343
8
3
18
58
906
6
89
12
24
15
1,285
227
128
386
3
74
10
119
228
46
474
26
133
4

Regions

89
58
45
41
41
35
31
30
30
29
28
28
28
26
16
16
14
12
12
10
10
10
9
8
8
8
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
795
495
2
2
2
117
195
102
53
23
704
26
134
526
174
627
63,380

Price

Date

Pages

Offers

1
280
1
1